tradingkey.logo
tradingkey.logo

Alteogen Enters Into A License Agreement With Biogen For Development And Commercialization Of Hybrozyme™-Based Subcutaneous Biologics

ReutersMar 25, 2026 12:30 PM

Alteogen Inc 196170.KQ:

  • ALTEOGEN ENTERS INTO A LICENSE AGREEMENT WITH BIOGEN FOR DEVELOPMENT AND COMMERCIALIZATION OF HYBROZYME™-BASED SUBCUTANEOUS BIOLOGICS

  • ALTEOGEN INC - TO RECEIVE $20 MILLION UPFRONT AND $10 MILLION UPON SECOND PRODUCT DEVELOPMENT

  • ALTEOGEN INC - ELIGIBLE FOR UP TO $549 MILLION IN MILESTONE PAYMENTS FOR TWO PRODUCTS

  • ALTEOGEN INC - FOLLOWING COMMERCIALIZATION, CO ENTITLED TO RECEIVE ROYALTIES BASED ON NET SALES

  • ALTEOGEN INC - BIOGEN HOLDS OPTION TO DEVELOP THIRD PRODUCT UNDER AGREEMENT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI